Solmaz, İ. Et Al. 2022. A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients. Turkish Journal of Medical Sciences , vol.52, no.4 , 1299-1310.

Solmaz, İ., KAPLAN, O., ÇELEBİER, M., LAY, İ., & Anlar, B., (2022). A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients. Turkish Journal of Medical Sciences , vol.52, no.4, 1299-1310.

Solmaz, İSMAİL Et Al. "A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients," Turkish Journal of Medical Sciences , vol.52, no.4, 1299-1310, 2022

Solmaz, İSMAİL Et Al. "A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients." Turkish Journal of Medical Sciences , vol.52, no.4, pp.1299-1310, 2022

Solmaz, İ. Et Al. (2022) . "A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients." Turkish Journal of Medical Sciences , vol.52, no.4, pp.1299-1310.

@article{article, author={İSMAİL SOLMAZ Et Al. }, title={A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients}, journal={Turkish Journal of Medical Sciences}, year=2022, pages={1299-1310} }